These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 7679413

  • 21. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.
    Hansen BE, Nielsen CH, Madsen HO, Ryder LP, Jakobsen BK, Svejgaard A.
    Tissue Antigens; 2011 Mar; 77(3):229-34. PubMed ID: 21299528
    [Abstract] [Full Text] [Related]

  • 22. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
    Xu M, Jackson R, Adams S, Humphreys RE.
    Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
    [Abstract] [Full Text] [Related]

  • 23. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R, Voskuhl R, Flerlage M, McFarlin DE, McFarland HF.
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [Abstract] [Full Text] [Related]

  • 24. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
    Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schröder S, Seissler J, Scherbaum WA, Kalbacher H.
    Exp Clin Endocrinol Diabetes; 1999 Oct; 107(3):166-71. PubMed ID: 10376440
    [Abstract] [Full Text] [Related]

  • 25. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A, Bloemhoff W, De Vries RR, Ottenhoff TH.
    Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
    Markovic-Plese S, Fukaura H, Zhang J, al-Sabbagh A, Southwood S, Sette A, Kuchroo VK, Hafler DA.
    J Immunol; 1995 Jul 15; 155(2):982-92. PubMed ID: 7541828
    [Abstract] [Full Text] [Related]

  • 30. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N, Altmann DM, Ascough S, David CS, Lassmann H, Ben-Nun A.
    J Immunol; 2009 Sep 01; 183(5):3531-41. PubMed ID: 19648275
    [Abstract] [Full Text] [Related]

  • 31. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ.
    J Clin Invest; 1997 May 15; 99(10):2405-15. PubMed ID: 9153283
    [Abstract] [Full Text] [Related]

  • 32. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA, Duffin KL, Smith CE, Welply JK, Howard SC, Schwartz BD, Woulfe SL.
    J Immunol; 1995 Dec 15; 155(12):5655-62. PubMed ID: 7499850
    [Abstract] [Full Text] [Related]

  • 33. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules.
    Mustafa AS.
    Nutrition; 1995 Dec 15; 11(5 Suppl):657-60. PubMed ID: 8748245
    [Abstract] [Full Text] [Related]

  • 34. Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.
    Huh J, Yao K, Quigley L, Ludwin SK, McFarland HF, Muraro PA, Martin R, Ito K.
    J Neuroimmunol; 2004 Jun 15; 151(1-2):94-102. PubMed ID: 15145608
    [Abstract] [Full Text] [Related]

  • 35. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
    Klyushnenkova EN, Kouiavskaia DV, Kodak JA, Vandenbark AA, Alexander RB.
    Prostate; 2007 Jul 01; 67(10):1019-28. PubMed ID: 17455230
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antigen presentation mediated by recycling of surface HLA-DR molecules.
    Pinet V, Vergelli M, Martin R, Bakke O, Long EO.
    Nature; 1995 Jun 15; 375(6532):603-6. PubMed ID: 7540726
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH, Macklin KD, Conti-Fine BM.
    J Autoimmun; 1996 Feb 15; 9(1):67-77. PubMed ID: 8845056
    [Abstract] [Full Text] [Related]

  • 40. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H.
    Proc Natl Acad Sci U S A; 1990 Oct 15; 87(20):7968-72. PubMed ID: 1700423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.